Abstract:sations. Alexithymic trait scores were characterized using established classification scores (scores 6 61). Statistical analyses were carried out in a 2-step logistic regression approach. All possible factors were entered simultaneously in a single block. All 2-way interactions between the possible risk factors were included. To select significant interactions, a backward elimination procedure with a threshold of p ! 0.20 was used. The final sample included 83 patients, with 73.5% males. The mean time to treatment was 176.75 8 239.65 min. In the analyses, 36 patients (43.4%) were allocated to the cases, 47 patients (56.6%) to the controls. Table 1 lists the frequencies of factors concerning the awareness of the disease and care-seeking behavior. None of the possible confounding factors taken into account differed between cases and controls in a statistically significant manner. However, the association between alexithymia (OR for cases 3.7, 95% CI 1.3–10.1) and contact with primary care prior to hospitalization (OR for cases 3.5, 95% CI 1.3–9.3) was statistically significant. No difference was found between cases and controls with regard to diagnosis of lifetime anxiety and depression. The multivariate analysis confirms the differences indicated by the univariate model but the two factors did not show any interaction, since the copresence of the two risk factors produced a cumulative risk without significant amplification (OR approx. 15.5, 95% CI 2.85–84.6; p ! 0.0001). The study shows that low emotional awareness, measured by alexithymia, and having had contact with primary care were associated with increased time to treatment in STEMI. No interaction was found between the two factors. An early study of Kenyon et al. [6] found evidence that the presence of alexithymia predicted a delay in seeking treatment in AMI. A study of O’Carroll et al. [7] , 10 years later, found some differences in alexithymia when comparing a group of patients with AMI who were prompt care seekers ( ! 4 h), and a group of late AMI care seekers ( 1 4 h) but these differences did not reach the threshold for statistical significance. Even so the results of such studies are partially in agreement with our data; the extension of their study sample might have biased the results since STEMI is the severest form of AMI and the only in which the delay in medical intervention is currently known to be of great danger [2] . On the other hand, ours is the first report in the literature exploring alexithymia as a potential risk factor for delay in seeking care in STEMI and also the first study to divide cases and controls with the delayed time known to be associated with a poor outcome (2 h) [2] . Sociodemographic and clinical variables did not independently appear to explain the delay. These results partially confirm the previous findings [8] . However, there appears to be some contradictory findings concerning consultation with a primary care The elapsed time between a person experiencing pain or discomfort due to an acute myocardial infarction (AMI) with ST segment elevation (STEMI) and his/her arrival at a hospital seeking care is crucial for survival. In fact, the degree of myocardial necrosis is related to the length of the ischemic episode [1] , and survival depends on the early provision of reperfusion techniques. If reperfusion occurs within 2 h, some preservation of myocardial function is achieved; after this period, life expectancy or survival decreases drastically [2] . The most important factor impacting on longer time to treatment is the patient’s decision to delay seeking care [1] . Thus, psychological variables such as alexithymia influencing the decision may be relevant. Unfortunately many of the findings with respect to psychosocial factors in delayed care seeking are still controversial [3] . We sought to explore psychological factors that might explain the delay in seeking care in STEMI with particular attention to alexithymia. Consecutive patients aged 18–85 years, admitted to a Cardiology Ward at Cagliari University Hospital, from April 2010 to June 2011, diagnosed with STEMI according to the European Society of Cardiology guidelines [2] were eligible for this study. The study sample was divided based on ‘time to treatment’, defined as the interval between the onset of symptoms and the first diagnostic ECG: controls = early care-seeking patients ( ! 2 h); cases = late care-seeking patients ( 1 2 h). A form was to be filled in to record sociodemographic data, health service utilization and risk factors [4] ; the study adopted the nonpatient version of the SCID-I-DSM-IV [4] and the Italian version of the 20-item Toronto Alexithymia Scale (TAS-20) [5] , a self-reporting checklist measuring the ability to identify and describe feelings and to distinguish between feelings and bodily senReceived: February 27, 2012 Accepted after revision: June 16, 2012 Published online: March 28, 2013

Resin hemoperfusion in acute digoxin intoxication.

MAM: more than just a housekeeper.

Tenth case of bilateral hemifacial spasm treated by microvascular decompression: Review of the pathophysiology

[Historical Review of Hemifacial Spasm]

Terrien's marginal degeneration associated with posterior polymorphous dystrophy.

Developmental vascular anomaly associated hemi facial spasms and botox injections therapy

[Role of endoscopy and vascular decompression in the treatment of hemifacial spasm]

Active site studies of ribulose-1,5-bisphosphate carboxylase/oxygenase with pyridoxal 5'-phosphate.

A study on phytochemical analysis and antimicrobial activity of Hyptis suaveolens ( L . ) poit

Unilateral periocular spasm

Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm

Alexithymia Is Associated with Delayed Treatment Seeking in Acute Myocardial Infarction

Microvascular decompression for hemifacial spasm : Surgical techniques and intraoperative monitoring

Galectin-1 expression in activated pancreatic satellite cells promotes fibrosis in chronic pancreatitis/pancreatic cancer via the TGF-β1/Smad pathway.

Microvascular decompression for hemifacial spasm: A systematic review of vascular pathology, long term treatment efficacy and safety

Fully endoscopic microvascular decompression for hemifacial spasm: a clinical study and analysis

[Microvascular decompression in hemifacial spasm: 13 cases report and review of the literature]

Clinical research progress of hemifacial spasm

The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms

Clinical Application of Botulinum Toxin for Hemifacial Spasm

[Neuro-vascular decompression in hemifacial spasm: anatomical, electrophysiological and therapeutic results apropos of 100 cases]